Last update 01 Nov 2024

CH-001

Overview

Basic Info

Drug Type
siRNA
Synonyms-
Target-
Mechanism
RNA interference
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes Mellitus
Originator Organization
Fabrus, Inc.Fabrus, Inc.
Active Organization-
Inactive Organization
Fabrus, Inc.Fabrus, Inc.
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with CH-001
JPRN-UMIN000006928 / RecruitingIIT
Efficacy and safety of CH-001 in patients with chronic hepatitis C or NAFLD/NASH (placebo comparative study) - Use of CH-001 in HCV or NAFLD/NASH
100 Clinical Results associated with CH-001
Login to view more data
100 Translational Medicine associated with CH-001
Login to view more data
100 Patents (Medical) associated with CH-001
Login to view more data
100 Deals associated with CH-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes MellitusPreclinical-
Fabrus, Inc.Fabrus, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free